• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy.

作者信息

Jiang Baijia, Patino Maria M, Gross Andrew J, Leong Stanley P L, Moretto John C, Kashani-Sabet Mohammed, Kim Kevin B

机构信息

California Pacific Medical Center, San Francisco, California.

University of California San Francisco, San Francisco, California.

出版信息

JAAD Case Rep. 2017 Dec 18;4(1):13-16. doi: 10.1016/j.jdcr.2017.06.014. eCollection 2018 Jan.

DOI:10.1016/j.jdcr.2017.06.014
PMID:29296642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5739149/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0c/5739149/048d50f6be20/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0c/5739149/e4625b0ab59d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0c/5739149/048d50f6be20/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0c/5739149/e4625b0ab59d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c0c/5739149/048d50f6be20/gr2.jpg

相似文献

1
Diffuse granulomatous panniculitis associated with anti PD-1 antibody therapy.与抗PD-1抗体治疗相关的弥漫性肉芽肿性脂膜炎。
JAAD Case Rep. 2017 Dec 18;4(1):13-16. doi: 10.1016/j.jdcr.2017.06.014. eCollection 2018 Jan.
2
Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma.纳武利尤单抗诱导的晚期黑色素瘤患者类肉瘤样肉芽肿反应
Chest. 2016 May;149(5):e133-6. doi: 10.1016/j.chest.2015.10.082.
3
Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.转移性葡萄膜黑色素瘤在单独接受抗 PD-1 治疗后进展，随后接受抗 CTLA-4 和抗 PD-1 联合治疗，获得持久缓解。
J Immunother Cancer. 2018 Feb 12;6(1):13. doi: 10.1186/s40425-018-0322-1.
4
Immune checkpoint blocker-related sarcoid-like granulomatous inflammation: a rare adverse event detected in lymph node aspiration cytology of patients treated for advanced malignant melanoma.免疫检查点抑制剂相关的类肉瘤样肉芽肿性炎症：在接受晚期恶性黑色素瘤治疗的患者的淋巴结细针抽吸细胞学中检测到的一种罕见不良事件。
Hum Pathol. 2019 Sep;91:69-76. doi: 10.1016/j.humpath.2019.07.001. Epub 2019 Jul 4.
5
Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma.纳武利尤单抗致 IV 期黑色素瘤患者迟发性严重胃十二指肠炎和胆管炎。
Immunotherapy. 2019 Aug;11(12):1005-1013. doi: 10.2217/imt-2019-0077. Epub 2019 Jul 15.
6
Acute hypophysitis secondary to nivolumab immunotherapy in a patient with metastatic melanoma.一名转移性黑色素瘤患者接受纳武单抗免疫治疗继发急性垂体炎。
Int J Crit Illn Inj Sci. 2017 Jul-Sep;7(3):177-180. doi: 10.4103/IJCIIS.IJCIIS_15_17.
7
BRAF Inhibitor-Induced Panniculitis: Appearance on 18F-FDG PET/CT.BRAF 抑制剂诱导的脂膜炎：18F-FDG PET/CT 表现。
Clin Nucl Med. 2016 Mar;41(3):e149-51. doi: 10.1097/RLU.0000000000001027.
8
Rapidly Evolving Extensive Fluorodeoxyglucose-Positive Soft-Tissue Activity During Nivolumab Therapy.
JAMA Oncol. 2019 May 1;5(5):730-731. doi: 10.1001/jamaoncol.2018.6431.
9
Early assessment with F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.采用 F-2-氟-2-脱氧葡萄糖正电子发射断层扫描/计算机断层扫描早期评估预测纳武利尤单抗治疗透明细胞肾细胞癌的短期预后。
BMC Cancer. 2019 Apr 2;19(1):298. doi: 10.1186/s12885-019-5510-y.
10
Interstitial granulomatous dermatitis and granulomatous arteritis in the setting of PD-1 inhibitor therapy for metastatic melanoma.在转移性黑色素瘤的PD-1抑制剂治疗背景下出现的间质性肉芽肿性皮炎和肉芽肿性动脉炎。
J Cutan Pathol. 2020 Jan;47(1):65-69. doi: 10.1111/cup.13562. Epub 2019 Aug 25.

引用本文的文献

1
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.CTLA4和PD1阻断辅助治疗黑色素瘤后出现的肉芽肿性和类结节病样免疫相关不良事件：ECOG-ACRIN E1609和SWOG S1404 III期试验的联合分析及文献综述
Cancers (Basel). 2023 Apr 29;15(9):2561. doi: 10.3390/cancers15092561.
2
Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors.抗 PD-1 治疗和 BRAF 抑制剂的皮肤不良反应。
Curr Treat Options Oncol. 2020 Mar 19;21(4):29. doi: 10.1007/s11864-020-0721-7.
3

本文引用的文献

1
Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma.一名肺腺癌患者出现的与纳武单抗相关的皮肤结节病。
JAAD Case Rep. 2017 Apr 14;3(3):208-211. doi: 10.1016/j.jdcr.2017.02.015. eCollection 2017 May.
2
Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy.在伊匹单抗和纳武单抗联合治疗中观察到的免疫相关性结节病。
JAAD Case Rep. 2016 Jul 14;2(3):264-8. doi: 10.1016/j.jdcr.2016.05.002. eCollection 2016 May.
3
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Spontaneous Resolution of Idiopathic Panniculitis: Role of F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnosis and follow-up.
特发性脂膜炎的自发缓解：F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在诊断和随访中的作用
Indian J Nucl Med. 2018 Jul-Sep;33(3):248-249. doi: 10.4103/ijnm.IJNM_42_18.
纳武利尤单抗与伊匹木单抗联合用药或单药治疗初治黑色素瘤
N Engl J Med. 2015 Jul 2;373(1):23-34. doi: 10.1056/NEJMoa1504030. Epub 2015 May 31.
4
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.纳武利尤单抗对比化疗用于 CTLA-4 治疗后进展的晚期黑色素瘤患者（CheckMate 037）：一项随机、对照、开放标签、III 期临床试验。
Lancet Oncol. 2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8. Epub 2015 Mar 18.
5
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor.两例BRAF突变转移性黑色素瘤患者接受BRAF抑制剂和MEK抑制剂联合治疗时脂膜炎的临床观察
Eur J Dermatol. 2015 Apr;25(2):177-80. doi: 10.1684/ejd.2014.2512.
6
Nivolumab in previously untreated melanoma without BRAF mutation.纳武利尤单抗治疗未经 BRAF 突变检测的初治黑色素瘤。
N Engl J Med. 2015 Jan 22;372(4):320-30. doi: 10.1056/NEJMoa1412082. Epub 2014 Nov 16.
7
Panniculitis in patients treated with BRAF inhibitors: a case series.接受BRAF抑制剂治疗患者的脂膜炎：病例系列
Am J Dermatopathol. 2014 Jun;36(6):493-7. doi: 10.1097/DAD.0000000000000023.
8
Case of vemurafenib-induced Sweet's syndrome.维莫非尼诱发的Sweet综合征病例。
J Dermatol. 2014 Sep;41(9):817-20. doi: 10.1111/1346-8138.12430. Epub 2014 Mar 12.
9
[Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].[一名接受甲磺酸伊马替尼和达沙替尼治疗的慢性粒细胞白血病患者的复发性嗜中性脂膜炎]
Ann Dermatol Venereol. 2011 Feb;138(2):135-9. doi: 10.1016/j.annder.2010.11.009. Epub 2010 Dec 28.
10
New observations in the histopathology of erythema nodosum.
J Invest Dermatol. 1975 Nov;65(5):441-6. doi: 10.1111/1523-1747.ep12608184.